Abstract
Squamous cell carcinoma is the most common malignant tumor of the penis and scrotum. The risk of these rare tumors has been linked to lack of circumcision for penile cancer, occupational exposure to carcinogens for scrotal cancer, and exposure to human papillomavirus for both. Although there have been no randomized controlled trials, several treatment strategies have emerged consisting of surgery, radiotherapy, chemotherapy for advanced disease, and multimodal therapy for locally advanced disease. More effective treatment for metastatic squamous cell carcinoma of the penis or scrotum is urgently needed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
Vyas R, et al. Squamous cell carcinoma of the scrotum: a look beyond the chimneystacks. World J Clin Cases. 2014;2(11):654–60.
Christodoulidou M, et al. Epidemiology of penile cancer. Curr Probl Cancer. 2015;39(3):126–36.
Dillner J, et al. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol. Supplementum. 2000;205:189–93.
Licklider S. Jewish penile carcinoma. J Urol. 1961;86:98.
Favorito LA, et al. Epidemiologic study on penile cancer in Brazil. Int Braz J Urol: Off J Braz Soc Urol. 2008;34(5):587–91. discussion 591–3.
Chaux A, Cubilla AL. Advances in the pathology of penile carcinomas. Hum Pathol. 2012;43(6):771–89.
Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The photochemotherapy follow-up study. N Engl J Med. 1990;322(16):1093–7.
Djajadiningrat RS, et al. Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome. J Urol. 2015;193(2):526–31.
de Sousa ID, et al. Prevalence of human papillomavirus in penile malignant tumors: viral genotyping and clinical aspects. BMC Urol. 2015;15:13.
Chaux A, Cubilla AL. The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin Diagn Pathol. 2012;29(2):67–71.
Chaux A, et al. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses. Urol Oncol. 2014;32(2):171–7.
Rocha RM, et al. A clinical, pathologic, and molecular study of p53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis. Hum Pathol. 2012;43(4):481–8.
Lopes A, et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol. 2002;168(1):81–6.
Mannweiler S, et al. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression. J Am Acad Dermatol. 2013;69(1):73–81.
Dillon MT, Harrington KJ. Human papillomavirus-negative pharyngeal cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33(29):3251–61.
Gunia S, et al. p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study. J Urol. 2012;187(3):899–907.
Hakenberg OW, et al. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2015;67(1):142–50.
Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol. 2009;27(2):169–77.
Edge S, Byrd D, Compton C. Penis. In: AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
Leijte JA, et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161–8.
Alkatout I, et al. Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination. Urol Oncol. 2011;29(6):774–81.
Lont AP, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 2003;91(6):493–5.
Alnajjar HM, et al. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol. 2012;62(5):923–8.
Meijer RP, et al. Long-term follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759–62.
Shabbir M, et al. Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol. 2011;59(1):142–7.
Li J, et al. Organ-sparing surgery for penile cancer: complications and outcomes. Urology. 2011;78(5):1121–4.
de Crevoisier R, et al. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys. 2009;74(4):1150–6.
Crook J, Jezioranski J, Cygler JE. Penile brachytherapy: technical aspects and postimplant issues. Brachytherapy. 2010;9(2):151–8.
Pagliaro LC, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28(24):3851–7.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, Penile cancer, version 1.2016; http: NCCN.org, accessed March 22, 2016.
Zhu Y, et al. New N staging system of penile cancer provides a better reflection of prognosis. J Urol. 2011;186(2):518–23.
Bermejo C, et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol. 2007;177(4):1335–8.
Djajadiningrat RS, et al. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer. Clin Genitourin Cancer. 2015;13(1):44–9.
Pizzocaro G, Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol. 1988;27(6b):823–4.
Leijte JA, et al. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol. 2007;52(2):488–94.
Graafland NM, et al. Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol. 2011;185(3):888–93.
Dickstein RJ, et al. Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy. BJU Int. 2016;117(1):118–25.
Sharma P, et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol. 2015;33(11)):496 e17–23.
Burt LM, Shrieve DC, Tward JD. Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys. 2014;88(1):94–100.
Kunos C, et al. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114(3):537–46.
Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009;27(2):221–5.
Pond GR, et al. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. Clin Genitourin Cancer. 2014;12(6):440–6.
Di Lorenzo G, et al. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int. 2012;110(11 Pt B):E661–6.
Haas GP, et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol. 1999;161(6):1823–5.
Theodore C, et al. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol: Off J Eur Soc Med Oncol/ESMO. 2008;19(7):1304–7.
Nicholson S, et al. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001). Br J Cancer. 2013;109(10):2554–9.
Zhang S, Zhu Y, Ye D. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy. Oncotarget. 2015;6(31):32212–9.
Houédé N, et al. Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma. BJU Int. 2016;117:444–9.
Di Lorenzo G, et al. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol. 2011;60(6):1280–4.
Wang J, Pettaway CA, Pagliaro LC. Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes. Urology. 2015;85(5):1104–10.
Rescigno P, et al. Combination of docetaxel and cetuximab for penile cancer: a case report and literature review. Anti-Cancer Drugs. 2012;23(5):573–7.
Brown A, et al. Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases. Urology. 2014;83(1):159–65.
Carthon BC, et al. Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis. BJU Int. 2014;113(6):871–7.
Necchi A, et al. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol: Off J Am Soc Clin Oncol. 2011;29(22):e650–2.
Necchi, A, et al. Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed. Clin Genitourin Cancer. 2015; online ahead of print.
Men HT, et al. A case of penile squamous cell carcinoma treated with a combination of antiepidermal growth factor receptor antibody and chemotherapy. Anti-Cancer Drugs. 2014;25(1):123–5.
Chaux A, et al. The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Hum Pathol. 2013;44(12):2690–5.
Wang J, et al. Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma (meeting abstract). J Clin Oncol. 2015;33(suppl 7):abstr 393.
Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56–61.
Starr P. Encouraging results for pembrolizumab in head and neck cancer. Am Health Drug Benefits. 2015;8(Spec Issue):16.
Flaherty A, et al. Implications for human papillomavirus in penile cancer. Urol Oncol. 2014;32(1):53 e1–8.
Barber J. The development of a clinical trial protocol to test the timing and effectiveness of adjuvant and neoadjuvant therapy in locally advanced penile cancer. Curr Probl Cancer. 2015;39(3):173–85.
Boffetta P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control: CCC. 1997;8(3):444–72.
Roush GC, Schymura MJ, Flannery JT. Secular and age distribution of scrotal cancer in Connecticut and a review of United States literature. Cancer. 1984;54(3):596–601.
Taniguchi S, et al. Squamous cell carcinoma of the scrotum. Dermatology. 1996;193(3):253–4.
Matoso A, et al. Squamous neoplasia of the scrotum: a series of 29 cases. Am J Surg Pathol. 2014;38(7):973–81.
Andrews PE, Farrow GM, Oesterling JE. Squamous cell carcinoma of the scrotum: long-term followup of 14 patients. J Urol. 1991;146(5):1299–304.
McDonald MW. Carcinoma of scrotum. Urology. 1982;19(3):269–74.
Huen KH, et al. Scrotal abscess as initial presentation of squamous cell carcinoma. Case Rep Urol. 2013;2013:807346.
Verhoeven RH, et al. Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989. Br J Cancer. 2010;103(9):1462–6.
Oluwasanmi JO, Williams AO, Alli AF. Superficial cancer in Nigeria. Br J Cancer. 1969;23(4):714–28.
Criton S, Aravindan KP. Bowenoid papulosis turning to squamous cell carcinoma. Indian J Dermatol Venereol Leprol. 1998;64(1):37–9.
Lowe FC. Squamous cell carcinoma of the scrotum. J Urol. 1983;130(3):423–7.
Rosevear HM, et al. Utility of (1)(8)F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Urol Oncol. 2012;30(5):723–6.
Azike JE. A review of the history, epidemiology and treatment of squamous cell carcinoma of the scrotum. Rare Tumors. 2009;1(1):e17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pagliaro, L. (2016). Squamous Cell Carcinoma of the Penis and Scrotum. In: Pagliaro, L. (eds) Rare Genitourinary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-30046-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-30046-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30044-3
Online ISBN: 978-3-319-30046-7
eBook Packages: MedicineMedicine (R0)